Compromising KCC2 transporter activity enhances the development of continuous seizure activity

Area of Science:

• Neuroscience
• Molecular Biology
• Epilepsy Research

Background:

• Impaired neuronal inhibition is linked to increased seizure occurrence and severity.
• Fast synaptic inhibition is primarily mediated by GABAARs, regulated by KCC2's maintenance of low intracellular chloride.
• KCC2 function is crucial for hyperpolarizing GABAergic inhibition in adult neurons.

Purpose of the Study:

• To investigate the impact of decreased KCC2 transport function on seizure event severity.
• To understand the role of KCC2 in seizure termination mechanisms.

Main Methods:

• Utilized in vitro models of epileptiform activity (0-Mg(2+) ACSF and 4-aminopyridine) in acute mouse brain slices.
• Employed the selective KCC2 inhibitor VU0463271.
• Examined brain slices from KCC2-Ser940Ala (S940A) point-mutant mice.

Main Results:

• Reduced KCC2 transport function significantly increased the duration of seizure-like events (SLEs), leading to non-terminating discharges.
• The KCC2-S940A mutation exacerbated susceptibility to continuous clonic-like discharges, an in vitro model of status epilepticus.
• KCC2 transport activity was identified as a critical determinant of seizure duration and termination.

Conclusions:

• KCC2 transport function plays a vital role in regulating seizure severity and duration.
• Therapeutic strategies aimed at potentiating KCC2 transport function are needed to reduce seizure severity and prevent status epilepticus.